Research Advances and Clinical Impact of New Data From Crohn’s and Colitis Congress^® 2021*

At the 2021 virtual congress, I was excited by select studies on emerging therapeutic approaches that remind us there is more to treating IBD than suppressing the immune system.

Bruce E. Sands, MD, MS Released: March 1, 2021

In this commentary, I present my take on interesting new data from the 2021 virtual Crohn’s & Colitis Congress on the relationship between visceral adipose tissue and outcomes for patients with IBD and the role of diet in IBD management.

Anita Afzali, MD, MPH, FACG Released: March 5, 2021